In the 20 years since Barbara Corkey, Ph.D., was named Editor in Chief of the journal Obesity, obesity among adults has risen significantly. Data from the National Center for Health Statistics show that one third of U.S. ...
Nov 2, 2022
0
10
Electroconvulsive therapy (ECT) is a treatment reserved for the most severe cases of depression, bipolar disorder and schizophrenia. Positive results are not guaranteed.
Oct 31, 2022
0
130
It was the information she couldn't find that led Amy Kirkham, an assistant professor in the University of Toronto's Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.
Oct 28, 2022
0
2
Preliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small cell lung cancer (NSCLC) and other solid tumors, suggest that it may have the potential to both halt tumor growth by ...
Oct 28, 2022
0
14
Researchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in a phase I clinical trial. Until now, no other drug has been able to do this safely and effectively.
Oct 26, 2022
0
10
Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones. Now, a team of University of Illinois Chicago ...
Oct 25, 2022
0
2
When a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.
Oct 25, 2022
0
2
An analysis of six studies has found that electroconvulsive therapy (ECT) is better at quickly relieving major depression than ketamine, a team of researchers reports in JAMA Psychiatry on October 19.
Oct 19, 2022
0
21
Nasal vaccines could still be a powerful future weapon in the fight against COVID-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
Oct 18, 2022
0
51
Researchers led by Prof. Zhang Xin at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS) combined the 9.4 T static magnetic field (SMF) with a commonly used anti-cancer drug imatinib mesylate ...
Oct 14, 2022
0
7
